These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28476022)

  • 41. Biochemical characterization of the medaka (Oryzias latipes) orthologue for mammalian tissue-type transglutaminase (TG2).
    Takada Y; Watanabe Y; Okuya K; Tatsukawa H; Hashimoto H; Hitomi K
    Biosci Biotechnol Biochem; 2017 Mar; 81(3):469-474. PubMed ID: 27855535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
    Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional control of transglutaminase 2 expression in mouse apoptotic thymocytes.
    Sándor K; Daniel B; Kiss B; Kovács F; Szondy Z
    Biochim Biophys Acta; 2016 Aug; 1859(8):964-74. PubMed ID: 27262403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
    Min B; Park H; Lee S; Li Y; Choi JM; Lee JY; Kim J; Choi YD; Kwon YG; Lee HW; Bae SC; Yun CO; Chung KC
    Oncogene; 2016 Jul; 35(28):3718-28. PubMed ID: 26568304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1.
    Verderio E; Gaudry C; Gross S; Smith C; Downes S; Griffin M
    J Histochem Cytochem; 1999 Nov; 47(11):1417-32. PubMed ID: 10544215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
    Joshi S; Guleria R; Pan J; DiPette D; Singh US
    Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 55 kDa tissue transglutaminase cross-linking active isoform TG induces cell death.
    Fraij BM
    Mol Carcinog; 2015 Sep; 54(9):720-9. PubMed ID: 24464646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3.
    Castellví A; Pequerul R; Barracco V; Juanhuix J; Parés X; Farrés J
    Commun Biol; 2022 Apr; 5(1):354. PubMed ID: 35418200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-Exome Sequencing in a South American Cohort Links ALDH1A3, FOXN1 and Retinoic Acid Regulation Pathways to Autism Spectrum Disorders.
    Moreno-Ramos OA; Olivares AM; Haider NB; de Autismo LC; Lattig MC
    PLoS One; 2015; 10(9):e0135927. PubMed ID: 26352270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenosafranin inhibits nuclear localization of transglutaminase 2 without affecting its transamidase activity.
    Furutani Y; Toguchi M; Shrestha R; Kojima S
    Amino Acids; 2017 Mar; 49(3):483-488. PubMed ID: 27665106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer.
    Lewis TE; Milam TD; Klingler DW; Rao PS; Jaggi M; Smith DJ; Hemstreet GP; Balaji KC
    Urol Oncol; 2005; 23(6):407-12. PubMed ID: 16301118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of transglutaminase genes in patients with chronic periodontitis.
    Currò M; Matarese G; Isola G; Caccamo D; Ventura VP; Cornelius C; Lentini M; Cordasco G; Ientile R
    Oral Dis; 2014 Sep; 20(6):616-23. PubMed ID: 24112124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of allosteric regulation of transglutaminase 2 by GTP.
    Begg GE; Carrington L; Stokes PH; Matthews JM; Wouters MA; Husain A; Lorand L; Iismaa SE; Graham RM
    Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19683-8. PubMed ID: 17179049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
    Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
    J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TG or not TG: IgG-anti-tissue transglutaminase in systemic lupus erythematosus: new role for an old enzyme.
    Tanay A; Brickman CM; Gas S; Misgav N; Frayman A; Lehman D
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):878-9. PubMed ID: 12455168
    [No Abstract]   [Full Text] [Related]  

  • 56. Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: relevance for erythrocyte diseases with shortened cell lifespan.
    Lorand L; Murthy SN; Khan AA; Xue W; Lockridge O; Chishti AH
    Adv Enzymol Relat Areas Mol Biol; 2011; 78():385-414. PubMed ID: 22220479
    [No Abstract]   [Full Text] [Related]  

  • 57. Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis.
    Gelardi ELM; Caprioglio D; Colombo G; Del Grosso E; Mazzoletti D; Mattoteia D; Salamone S; Ferraris DM; Aronica E; Nato G; Buffo A; Rizzi M; Magrassi L; Minassi A; Garavaglia S
    Commun Biol; 2022 Sep; 5(1):895. PubMed ID: 36050388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a novel ALDH1A3-selective inhibitor by a chemical probe with unrelated bioactivity: An approach to affinity-based drug target discovery.
    Kamiyama H; Miyano M; Ito D; Kimura T; Hagiwara K; Kogai H; Kaburagi Y; Kotake Y; Takase Y
    Chem Biol Drug Des; 2023 Mar; 101(3):727-739. PubMed ID: 36334047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
    Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
    Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.
    Király R; Csosz E; Kurtán T; Antus S; Szigeti K; Simon-Vecsei Z; Korponay-Szabó IR; Keresztessy Z; Fésüs L
    FEBS J; 2009 Dec; 276(23):7083-96. PubMed ID: 19878304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.